Current Knowledge and Future Therapeutic Prospects in Symptomatic Intervertebral Disc Degeneration

키워드

참고문헌 (107)

1. Andersson GB, "Epidemiological features of chronic low-back pain", Lancet, 354, pp.581~585 (1999)
2. Kepler CK, "The molecular basis of intervertebral disc degeneration", Spine J, 13, pp.318~330 (2013)
3. Joo Han Kim, "Bench to Bed (B2B) Project; Intervertebral Disc Degeneration in Collaboration With Biospine", Neurospine, 17(1), pp.1~2 (2020), 대한척추신경외과학회[DOI]
4. Peng B, "Possible pathogenesis of painful intervertebral disc degeneration", Spine(Phila Pa 1976), 31, pp.560~566 (2006)
5. Park JJ, "Induction of proinflammatory cytokine production in intervertebral disc cells by macrophage-like THP-1 cells requires mitogen-activated protein kinase activity", J Neurosurg Spine, 24, pp.167~175 (2016)
6. Kim JH, "Activated macrophage-like THP-1 cells modulate anulus fibrosus cell production of inflammatory mediators in response to cytokines", Spine(Phila Pa 1976), 33, pp.2253~2259 (2008)
7. Fehlings MG, "The aging of the global population : the changing epidemiology of disease and spinal disorders", Neurosurgery, 77(Suppl 4), pp.S1~S5 (2015)
8. Boos N, "Classification of age-related changes in lumbar intervertebral discs: 2002 Volvo award in basic science", Spine (Phila Pa 1976), 27, pp.2631~2644 (2002)
9. Shapiro IM, "Is the spinal motion segment a diarthrodial polyaxial joint: what a nice nucleus like you doing in a joint like this?", Bone, 50, pp.771~776 (2012)
10. Rider SM, "Molecular mechanisms of intervertebral disc degeneration", Spine Surg Relat Res, 3, pp.1~11 (2019)
11. Purmessur D, "Notochordal cell-derived therapeutic strategies for discogenic back pain", Global Spine J, 3, pp.201~218 (2013)
12. Dowdell J, "Intervertebral disk degeneration and repair", Neurosurgery, 80, pp.S46~S54 (2017)[DOI]
13. Jahnke MR, "Proteoglycans of the human intervertebral disc. Electrophoretic heterogeneity of the aggregating proteoglycans of the nucleus pulposus", Biochem J, 251, pp.347~356 (1988)
14. Samartzis D, "Lumbar intervertebral disk degeneration", Orthop Clin North Am, 42, pp.11~12 (2011)
15. Walker MH, "Molecular basis of intervertebral disc degeneration", Spine J, 4, pp.S158~S166 (2004)
16. Ambard D, "Mechanical behavior of annulus fibrosus : a microstructural model of fibers reorientation", Ann Biomed Eng, 37, pp.2256~2265 (2009)
17. Buckwalter JA, "Aging and degeneration of the human intervertebral disc", Spine(Phila Pa 1976), 20, pp.1307~1314 (1995)
18. Roughley PJ, "Biology of intervertebral disc aging and degeneration:involvement of the extracellular matrix", Spine (Phila Pa 1976), 29, pp.2691~2699 (2004)
19. Antoniou J, "The human lumbar intervertebral disc : evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration", J Clin Invest, 98, pp.996~1003 (1996)
20. Weber A, "Interleukin-1beta(IL-1beta)processing pathway", Sci Signal, 3, pp.cm2~ (2010)
21. Gabay E, "Chronic blockade of interleukin-1(IL-1)prevents and attenuates neuropathic pain behavior and spontaneous ectopic neuronal activity following nerve injury", Eur J Pain, 15, pp.242~248 (2011)
22. Takahashi H, "Inflammatory cytokines in the herniated disc of the lumbar spine", Spine(Phila Pa 1976), 21, pp.218~224 (1996)
23. Ohtori S, "Pathomechanisms of discogenic low back pain in humans and animal models", Spine J, 15, pp.1347~1355 (2015)
24. Le Maitre CL, "Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc", J Pathol, 204, pp.47~54 (2004)
25. Kim JH, "p38 MAPK inhibition selectively mitigates inflammatory mediators and VEGF production in AF cells co-cultured with activated macrophage-like THP-1 cells", Osteoarthritis Cartilage, 17, pp.1662~1669 (2009)
26. Le Maitre CL, "Expression of receptors for putative anabolic growth factors in human intervertebral disc : implications for repair and regeneration of the disc", J Pathol, 207, pp.445~452 (2005)
27. Le Maitre CL, "The role of interleukin-1in the pathogenesis of human intervertebral disc degeneration", Arthritis Res Ther, 7, pp.R732~R745 (2005)[DOI]
28. Bachmeier BE, "Matrix metalloproteinase expression levels suggest distinct enzyme roles during lumbar disc herniation and degeneration", Eur Spine J, 18, pp.1573~1586 (2009)
29. Studer RK, "Human nucleus pulposus cells react to IL-6: independent actions and amplification of response to IL-1 and TNF-α", Spine(Phila Pa 1976), 36, pp.593~599 (2011)
30. Wang Y, "The role of IL-1βand TNF-α in intervertebral disc degeneration", Biomed Pharmacother, 131, pp.110660~ (2020)
31. Wang K, "Ligustilide alleviated IL-1β induced apoptosis and extracellular matrix degradation of nucleus pulposus cells and attenuates intervertebral disc degeneration in vivo", Int Immunopharmacol, 69, pp.398~407 (2019)
32. Jin H, "Baicalein inhibits the IL-1β-induced inflammatory response in nucleus pulposus cells and attenuates disc degeneration in vivo", Inflammatio, 42, pp.1032~1044 (2019)
33. Shi C, "MiR-202-3p regulates interleukin-1β-induced expression of matrix metalloproteinase 1 in human nucleus pulposus", Gene, 687, pp.156~165 (2019)
34. Kim JH, "Effect of biphasic electrical current stimulation on IL-1β-stimulated annulus fibrosus cells using in vitro microcurrent generating chamber system", Spine(Phila Pa 1976), 38, pp.E1368~76 (2013)
35. 김주한, "Matrix Degradative Enzymes and Their Inhibitors during Annular Inflammation : Initial Step of Symptomatic Intervertebral Disc Degeneration", 대한신경외과학회지, 55(5), pp.237~243 (2014), 대한신경외과학회
36. Kwon WK, "The role of hypoxia in angiogenesis and extracellular matrix regulation of intervertebral disc cells during inflammatory reactions", Neurosurgery, 81, pp.867~875 (2017)
37. Moon HJ, "Effects of secreted factors in culture medium of annulus fibrosus cells on microvascular endothelial cells : elucidating the possible pathomechanisms of matrix degradation and nerve ingrowth in disc degeneration", Osteoarthritis Cartilage, 22, pp.344~354 (2014)
38. Kepler CK, "Substance P stimulates production of inflammatory cytokines in human disc cells", Spine(Phila Pa 1976), 38, pp.E1291~E1299 (2013)
39. Purmessur D, "A role for TNFα in intervertebral disc degeneration : a non-recoverable catabolic shift", Biochem Biophys Res Commun, 433, pp.151~156 (2013)
40. Burke JG, "Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators", J Bone Joint Surg Br, 84, pp.196~201 (2002)
41. Navone SE, "Inflammatory mediators and signalling pathways controlling intervertebral disc degeneration", Histol Histopathol, 32, pp.523~542 (2017)
42. Shamji MF, "Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues", Arthritis Rheum, 62, pp.1974~1982 (2010)
43. Sakai D, "Advancing the cellular and molecular therapy for intervertebral disc disease", Adv Drug Deliv Rev, 84, pp.159~171 (2015)
44. Crean JK, "Matrix metalloproteinases in the human intervertebral disc: role in disc degeneration and scoliosis", Spine(Phila Pa 1976), 22, pp.2877~2884 (1997)
45. Kozaci LD, "Alterations in biochemical components of extracellular matrix in intervertebral disc herniation : role of MMP-2 and TIMP-2 in type II collagen loss", Cell Biochem Funct, 24, pp.431~436 (2006)
46. Gruber HE, "Immunolocalization of MMP-19 in the human intervertebral disc : implications for disc aging and degeneration", Biotech Histochem, 80, pp.157~162 (2005)
47. Roberts S, "Matrix metalloproteinases and aggrecanase: their role in disorders of the human intervertebral disc", Spine (Phila Pa 1976), 25, pp.3005~3013 (2000)
48. Weiler C, "2002SSE award competition in basic science : expression of major matrix metalloproteinases is associated with intervertebral disc degradation and resorption", Eur Spine J, 11, pp.308~320 (2002)
49. Mayer JE, "Genetic polymorphisms associated with intervertebral disc degeneration", Spine J, 13, pp.299~317 (2013)
50. Urban JP, "Degeneration of the intervertebral disc", Arthritis Res Ther, 5, pp.120~130 (2003)
51. Neidlinger-Wilke C, "Regulation of gene expression in intervertebral disc cells by low and high hydrostatic pressure", Eur Spine J, 15(Suppl 3), pp.S372~S378 (2006)
52. Licciardone JC, "Associations of cytokine concentrations with key osteopathic lesions and clinical outcomes in patients with nonspecific chronic low back pain : results from the osteopathic trial", J Am Osteopath Assoc, 112, pp.596~605 (2012)
53. Uçeyler N, "Differential expression of cytokines in painful and painless neuropathies", Neurology, 69, pp.42~49 (2007)
54. Wang K, "A cohort study comparing the serum levels of pro-or anti-inflammatory cytokines in patients with lumbar radicular pain and healthy subjects", Eur Spine J, 25, pp.1428~1434 (2016)
55. Gebhardt K, "The course of high-sensitive C-reactive protein in correlation with pain and clinical function in patients with acute lumbosciatic pain and chronic low back pain-a 6 months prospective longitudinal study", Eur J Pain, 10, pp.711~719 (2006)
56. Khan AN, "Inflammatory biomarkers of low back pain and disc degeneration : a review", Ann N Y Acad Sci, 1410, pp.68~84 (2017)
57. Jung WW, "Intervertebral disc degeneration-induced expression of pain-related molecules : glial cell-derived neurotropic factor as a key factor", J Neurosurg Anesthesiol, 23, pp.329~334 (2011)
58. Rothman SM, "Cytokine mRNA expression in painful radiculopathy", J Pain, 10, pp.90~99 (2009)
59. Bianchi M, "Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain", Eur J Pain, 12, pp.284~292 (2008)
60. Moon HJ, "Annulus fibrosus cells interact with neuron-like cells to modulate production of growth factors and cytokines in symptomatic disc degeneration", Spine(Phila Pa 1976), 37, pp.2~9 (2012)
61. Sainoh T, "Single intradiscal injection of the interleukin-6 receptor antibody tocilizumab provides short-term relief of discogenic low back pain; prospective comparative cohort study", J Orthop Sci, 21, pp.2~6 (2016)
62. John D. Koerner, "Correlation of Early Outcomes and Intradiscal Interleukin-6 Expression in Lumbar Fusion Patients", Neurospine, 17(1), pp.36~41 (2020), 대한척추신경외과학회[DOI]
63. Igarashi T, "2000 Volvo award winner in basic science studies: exogenous tumor necrosis factor-alpha mimics nucleus pulposus-induced neuropathology. Molecular, histologic, and behavioral comparisons in rats", Spine (Phila Pa 1976), 25, pp.2975~2980 (2000)
64. Freemont AJ, "The cellular pathobiology of the degenerate intervertebral disc and discogenic back pain", Rheumatology(Oxford), 48, pp.5~10 (2009)
65. Yoshida M, "Intervertebral disc cells produce tumor necrosis factor alpha, interleukin-1beta, and monocyte chemoattractant protein-1 immediately after herniation: an experimental study using a new hernia model", Spine(Phila Pa 1976), 30, pp.55~61 (2005)
66. Cohen SP, "A double-blind, placebo-controlled, doseresponse pilot study evaluating intradiscal etanercept in patients with chronic discogenic low back pain or lumbosacral radiculopathy", Anesthesiology, 107, pp.99~105 (2007)
67. Tobinick EL, "Perispinal TNF-alpha inhibition for discogenic pain", Swiss Med Wkly, 133, pp.170~177 (2003)
68. Huang P, "MAPK signaling in inflammation-associated cancer development", Protein Cell, 1, pp.218~226 (2010)
69. Kyriakis JM, "Mammalian MAPK signal transduction pathways activated by stress and inflammation : a 10-year update", Physiol Rev, 92, pp.689~737 (2012)
70. Gruber HE, "Senescent vs. non-senescent cells in the human annulus in vivo : cell harvest with laser capture microdissection and gene expression studies with microarray analysis", BMC Biotechnol, 10, pp.5~ (2010)
71. Freemont AJ, "Nerve growth factor expression and innervation of the painful intervertebral disc", J Pathol, 197, pp.286~292 (2002)
72. Freemont AJ, "Nerve ingrowth into diseased intervertebral disc in chronic back pain", Lancet, 350, pp.178~181 (1997)
73. Inoue G, "Exposure of the nucleus pulposus to the outside of the anulus fibrosus induces nerve injury and regeneration of the afferent fibers innervating the lumbar intervertebral discs in rats", Spine(Phila Pa 1976), 31, pp.1433~1438 (2006)
74. Yamauchi K, "Nerve growth factor of cultured medium extracted from human degenerative nucleus pulposus promotes sensory nerve growth and induces substance P in vitro", Spine(Phila Pa 1976), 34, pp.2263~2269 (2009)
75. Junxuan Ma, "Direct and Intervertebral DiscMediated Sensitization of Dorsal Root Ganglion Neurons by Hypoxia and Low pH", Neurospine, 17(1), pp.42~59 (2020), 대한척추신경외과학회[DOI]
76. Xiao WH, "Persistent low-frequency spontaneous discharge in A-fiber and C-fiber primary afferent neurons during an inflammatory pain condition", Anesthesiology, 107, pp.813~821 (2007)
77. Kim YS, "Coupled activation of primary sensory neurons contributes to chronic pain", Neuron, 91, pp.1085~1096 (2016)
78. Ohba T, "TNFalpha-induced NF-kappaB signaling reverses age-related declines in VEGF induction and angiogenic activity in intervertebral disc tissues", J Orthop Res, 27, pp.229~235 (2009)
79. Karamouzian S, "Frequency of lumbar intervertebral disc calcification and angiogenesis, and their correlation with clinical, surgical, and magnetic resonance imaging findings", Spine(Phila Pa 1976), 35, pp.881~886 (2010)
80. Olsson AK, "VEGF receptor signalling-in control of vascular function", Nat Rev Mol Cell Biol, 7, pp.359~371 (2006)
81. Kokubo Y, "Herniated and spondylotic intervertebral discs of the human cervical spine : histological and immunohistological findings in 500 en bloc surgical samples. Laboratory investigation", J Neurosurg Spine, 9, pp.285~295 (2008)
82. Agrawal A, "Cited2 modulates hypoxia-inducible factor-dependent expression of vascular endothelial growth factor in nucleus pulposus cells of the rat intervertebral disc", Arthritis Rheum, 58, pp.3798~3808 (2008)
83. Fujita N, "Vascular endothelial growth factor-A is a survival factor for nucleus pulposus cells in the intervertebral disc", Biochem Biophys Res Commun, 372, pp.367~372 (2008)
84. Kim JH, "Rabbit notochordal cells modulate the expression of inflammatory mediators by human annulus fibrosus cells cocultured with activated macrophage-like THP-1 cells", Spine(Phila Pa 1976), 37, pp.1856~1864 (2012)
85. Kwon WK, "Influence of rabbit notochordal cells on symptomatic intervertebral disc degeneration : anti-angiogenic capacity on human endothelial cell proliferation under hypoxia", Osteoarthritis Cartilage, 25, pp.1738~1746 (2017)
86. Nico B, "Nerve growth factor as an angiogenic factor", Microvasc Res, 75, pp.135~141 (2008)
87. Wuertz K, "Inflammatory mediators in intervertebral disk degeneration and discogenic pain", Global Spine J, 3, pp.175~184 (2013)
88. Santos PM, "Nerve growth factor : increased angiogenesis without improved nerve regeneration", Otolaryngol Head Neck Surg, 105, pp.12~25 (1991)
89. Cao P, "Intradiscal injection therapy for degenerative chronic discogenic low back pain with end plate Modic changes", Spine J, 11, pp.100~106 (2011)
90. Masuda K, "Osteogenic protein-1 injection into a degenerated disc induces the restoration of disc height and structural changes in the rabbit anular puncture model", Spine(Phila Pa 1976), 31, pp.742~754 (2006)
91. Imai Y, "Restoration of disc height loss by recombinant human osteogenic protein-1 injection into intervertebral discs undergoing degeneration induced by an intradiscal injection of chondroitinase ABC", Spine(Phila Pa 1976), 32, pp.1197~1205 (2007)
92. Moriguchi Y, "Biological treatment approaches for degenerative disk disease : a literature review of in vivo animal and clinical data", Global Spine J, 6, pp.497~518 (2016)
93. Yoshiki Takeoka, "Gene Therapy Approach for Intervertebral Disc Degeneration: An Update", Neurospine, 17(1), pp.3~14 (2020), 대한척추신경외과학회[DOI]
94. 한인보, "Moving Forward: Gene Therapy for Intervertebral Disc Degeneration", Neurospine, 17(1), pp.17~18 (2020), 대한척추신경외과학회[DOI]
95. Vadalà G, "Gene therapy for disc degeneration", Expert Opin Biol Ther, 7, pp.185~196 (2007)
96. Paul R, "Potential use of Sox9 gene therapy for intervertebral degenerative disc disease", Spine(Phila Pa 1976), 28, pp.755~763 (2003)
97. Nishida K, "Sustained transgene expression in intervertebral disc cells in vivo mediated by microbubble-enhanced ultrasound gene therapy", Spine(Phila Pa 1976), 31, pp.1415~1419 (2006)
98. Nishida K, "Gene therapy approach for disc degeneration and associated spinal disorders", Eur Spine J, 17(Suppl 4), pp.459~466 (2008)
99. Wehling P, "Transfer of genes to chondrocytic cells of the lumbar spine. Proposal for a treatment strategy of spinal disorders by local gene therapy", Spine (Phila Pa 1976), 22, pp.1092~1097 (1997)
100. Sakai D, "Stem cell therapy for intervertebral disc regeneration : obstacles and solutions", Nat Rev Rheumatol, 11, pp.243~256 (2015)
101. Vadalà G, "Mesenchymal stem cells injection in degenerated intervertebral disc : cell leakage may induce osteophyte formation", J Tissue Eng Regen Med, 6, pp.348~355 (2012)
102. Prockop DJ, "Mesenchymal stem", stromal cells(MSCs) : role as guardians of inflammation, 2012, pp.20, 14~20
103. Hwang MH, "Photobiomodulation of extracellular matrix enzymes in human nucleus pulposus cells as a potential treatment for intervertebral disk degeneration", Sci Rep, 8, pp.11654~ (2018)
104. Vo N, "Accelerated aging of intervertebral discs in a mouse model of progeria", J Orthop Res, 28, pp.1600~1607 (2010)
105. He S, "Senescence in health and disease", Cell, 169, pp.1000~1011 (2017)
106. Novais EJ, "Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice", Nat Commun, 12, pp.5213~ (2021)
107. Shao Z, "Senolytic agent Quercetin ameliorates intervertebral disc degeneration via the Nrf2", NF-κB axis, 2021, pp.29, 413~422

관련 논문AI추천